2024/0139,165 | METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE | Nov 07, 23 | May 02, 24 | Not available |
2024/0139,337 | METHOD FOR TREATING A CANCER AND/OR CANCER METASTASIS | Nov 02, 22 | May 02, 24 | Not available |
2024/0141,297 | USE OF MESENCHYMAL STEM CELLS OVEREXPRESSING PACER FOR THE TREATMENT OF DISEASES WITH INFLAMMATORY ORIGIN AND/OR COMPONENT | Mar 02, 22 | May 02, 24 | Not available |
2024/0141,037 | ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF | Mar 08, 23 | May 02, 24 | Not available |
2024/0131,006 | ANTI-FIBROTIC THERAPIES | Mar 01, 22 | Apr 25, 24 | Not available |
2024/0131,090 | PROBIOTIC COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF GASTROINTESTINAL DISORDERS | Mar 28, 22 | Apr 25, 24 | Not available |
2024/0131,191 | COMPOSITIONS AND METHODS FOR ENHANCING GAMMA DELTA T CELLS IN THE GUT | Aug 11, 23 | Apr 25, 24 | King's College London |
2024/0132,466 | PIPERIDINE-2,6-DIONE DERIVATIVES AND ULCERATIVE COLITIS TREATING | Dec 08, 23 | Apr 25, 24 | Not available |
2024/0123,090 | COMPOSITIONS AND METHODS FOR ENHANCING GAMMA DELTA T CELLS IN THE GUT | Aug 11, 23 | Apr 18, 24 | King's College London |
2024/0122,902 | TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS | Dec 20, 23 | Apr 18, 24 | Not available |
2024/0124,861 | Compositions and Methods for Modulating Growth of a Genetically Modified Gut Bacterial Cell | Dec 20, 23 | Apr 18, 24 | Not available |
2024/0115,625 | ROSEBURIA HOMINIS, EUBACTERIUM ELIGENS, AND COMBINATIONS THEREOF AS BIOTHERAPEUTICS | Feb 21, 23 | Apr 11, 24 | Not available |
2024/0115,649 | CASPASE INHIBITION TO ENHANCE REGENERATION AND REPAIR AFTER SKIN OR GUT INJURY AND TO TREAT BACTERIAL OR VIRAL INFECTIONS | Sep 29, 23 | Apr 11, 24 | Not available |
2024/0108,604 | TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS | Nov 17, 23 | Apr 04, 24 | Not available |
2024/0108,642 | GLYCAN THERAPEUTIC COMPOSITIONS AND RELATED METHODS THEREOF | Dec 11, 23 | Apr 04, 24 | Not available |
2024/0100,041 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING CCR9 INHIBITOR AND ANTI-IL-23 BLOCKING ANTIBODIES | Dec 06, 23 | Mar 28, 24 | CHEMOCENTRYX, INC. |
2024/0100,082 | METHODS AND COMPOSITION FOR TREATING METABOLIC SYNDROME | May 24, 23 | Mar 28, 24 | Not available |
2024/0091,169 | POLYACETYLENE COMPOUNDS FOR TREATING INFLAMMATORY DISEASES | Aug 24, 23 | Mar 21, 24 | Not available |
2024/0091,281 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INTESTINAL DAMAGE COMPRISING LEUCONOSTOC CITREUM STRAIN AS ACTIVE INGREDIENT | Feb 07, 22 | Mar 21, 24 | Not available |
2024/0091,324 | GASTROINTESTINAL HEALTH COMPOSITION | Oct 09, 20 | Mar 21, 24 | Anatara Lifesciences Ltd |